Patients with unresected locally advanced head and neck cancer had worse outcomes when they received xevinapant along with standard chemoradiotherapy.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/xevinapant-fails-phase-3-head-and-neck-cancer-2025a1000qqb?src=rss
Author :
Publish date : 2025-10-06 07:53:00
Copyright for syndicated content belongs to the linked Source.